Global Smart Insulin Pens Market Research Report 2022
Smart Insulin Pens is an electronic medical records device that reminds patient to take your medicine or tracks how much medicine patient taken.
Due to the COVID-19 pandemic, the global Smart Insulin Pens market size is estimated to be worth US$ 12 million in 2021 and is forecast to a readjusted size of US$ 22 million by 2028 with a CAGR of 8.6% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Smart Insulin Pens market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Smart Insulin Pens landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The global smart insulin pens market is dominated by few players from Europe and North America, key players include Emperra, Patients Pending, Roche, Diamesco, Companion Medical and Common Sensing, global top two players hold a share over 50%.
This report focuses on Smart Insulin Pens volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Smart Insulin Pens market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and South Korea, etc.
Global Smart Insulin Pens Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Smart Insulin Pens
Smart Pen Caps
Segment by Application
Home Care Settings
Hospitals & Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Emperra
Roche
Diamesco
Companion Medical
Patients Pending
Common Sensing
Jiangsu Delfu
Dnurse
Due to the COVID-19 pandemic, the global Smart Insulin Pens market size is estimated to be worth US$ 12 million in 2021 and is forecast to a readjusted size of US$ 22 million by 2028 with a CAGR of 8.6% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Smart Insulin Pens market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Smart Insulin Pens landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The global smart insulin pens market is dominated by few players from Europe and North America, key players include Emperra, Patients Pending, Roche, Diamesco, Companion Medical and Common Sensing, global top two players hold a share over 50%.
This report focuses on Smart Insulin Pens volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Smart Insulin Pens market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and South Korea, etc.
Global Smart Insulin Pens Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Smart Insulin Pens
Smart Pen Caps
Segment by Application
Home Care Settings
Hospitals & Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Emperra
Roche
Diamesco
Companion Medical
Patients Pending
Common Sensing
Jiangsu Delfu
Dnurse
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
